How should cost data in pragmatic randomised trials be analysed?

BMJ. 2000 Apr 29;320(7243):1197-200. doi: 10.1136/bmj.320.7243.1197.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Cost-Benefit Analysis
  • Costs and Cost Analysis*
  • Data Interpretation, Statistical
  • Randomized Controlled Trials as Topic / economics*